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Introduction {#sec1}
============

In the development and patterning of embryonic and adult tissues, secreted signaling molecules of the Wnt, Fgf, Hedgehog, and transforming growth factor β (TGF-β) families can act as morphogens to activate different transcriptional programs along a signaling gradient ([@bib37]). Ideas of how morphogens impart spatial information have been dominated by the assumption that these molecules form concentration gradients by diffusion, inducing dose-dependent responses in the receiving field of cells. However, it is becoming increasingly clear that for some ligands, for example, Hedgehog, Wnt, and Fgf, other mechanisms, such as short-range signaling activation, transcriptional feedback, and cellular rearrangements, underlie morphogen function ([@bib1], [@bib11], [@bib15]).

Regulation of Nodal signaling in the zebrafish embryo has long served as a paradigm for understanding how morphogens pattern tissues ([@bib42]). Nodals are secreted ligands that belong to the TGF-β superfamily of growth and differentiation factors. During vertebrate development, Nodal is required for stem cell maintenance, specification of mesoderm and endoderm (mesendoderm), and establishment of left-right asymmetry ([@bib44]). Recent work has also suggested that Nodal signaling is reactivated in advanced cancers, where it may be important for self-renewal of cancer stem cells ([@bib48]).

Nodal ligands signal through serine/threonine kinase receptor complexes comprising two type I receptors (Acvr1ba \[Taram-a\]), two type II receptors (Acvr2a/b), and the co-receptor Tdgf1 (Cripto/Oep) ([@bib42], [@bib44]). Ligand binding activates the receptors, after which the type I receptor phosphorylates the intracellular signal transducers Smad2 and Smad3, which then bind Smad4 ([@bib32]). These Smad2/3-Smad4 complexes accumulate in the nucleus, where, together with transcription factors such as Foxh1, Mixer, and Oct4, they regulate gene transcription ([@bib18]).

At zebrafish blastula stages, two Nodal-related ligands, Ndr1 (Squint) and Ndr2 (Cyclops), specify mesendoderm in marginal cells around the circumference of the embryo by inducing a Smad2-Smad4-Foxh1-dependent transcriptional program ([@bib17], [@bib23]). Ndr1/2 are thought to form a signaling gradient by diffusion, extending up to about ten cell tiers from the margin ([@bib14], [@bib25], [@bib42]). Indeed, expression of presumed long-range Nodal target genes such as *ta* (*ntla*) and *fscn1a* suggests low-level signaling up to ten cell tiers from the margin ([@bib5]). This appears supported by bimolecular fluorescent complementation experiments ([@bib25]). However, other Nodal target genes are expressed in up to five to six cell tiers from the margin, which coincides with nuclear accumulation of Smad2-GFP fusion protein ([@bib14]). Importantly, other signaling pathways, such as Bmp, Wnt, and Fgf, are also active at the margin, which can potentially co-regulate Nodal target genes and thus contribute to their expression domains.

Formation of the Nodal signaling domain at the correct time and of appropriate dimensions is thought to be controlled by a reaction-diffusion system ([@bib34], [@bib42]). This model requires positive and negative feedback, which is provided by Nodal-induced expression of both the ligands Ndr1/2 and the antagonists Lefty1 (Lft1) and Lefty2 (Lft2) ([@bib8], [@bib9]). Besides these feedback mechanisms, the model requires Lft1/2 to be more diffusible than Ndr1/2 ([@bib36], [@bib43]). These conditions are thought to allow Ndr1/2 to activate signaling at the margin, whereas Lft1/2 proteins would inhibit signaling in more distal cells. Overexpression studies have shown that Ndr1/2 and Lft1/2 can differentially diffuse and that Ndr1, but not Ndr2, can diffuse over a distance to activate signaling ([@bib6], [@bib7], [@bib36]). However, the importance of diffusion of endogenous Ndr1/2 remains unclear, as mesendoderm can develop normally in zygotic *ndr1* mutants ([@bib13], [@bib17], [@bib30]).

In addition to the negative feedback provided by Lft1/2, Nodal signaling is regulated by the *miR-430/427/302* family of microRNAs (miRNAs) ([@bib3], [@bib10], [@bib41]). At blastula stages, the *miR-430* family is the most abundant family of miRNAs in the zebrafish. Importantly, *miR-430* regulates *ndr1*, *lft1*, and *lft2*, but not *ndr2*, and this is thought to dampen Nodal signaling ([@bib10]). However, to what extent *miR-430*s contribute to the formation of the Nodal signaling domain is unknown.

To develop a specific readout for endogenous Nodal signaling, avoiding overexpression of any pathway components, we generated a transgenic zebrafish Nodal reporter line. Using this line combined with immunofluorescence for phosphorylated Smad2 (P-Smad2), we show that Nodal signals exclusively in cells that express Ndr1/2, up to five to six cell tiers from the margin. This prompted us to revisit the mechanism underlying the formation of the Nodal signaling domain. Our data do not support the reaction-diffusion model, but instead, we propose that Nodal activates signaling in a temporal window that is defined by a *miR-430*-mediated delay of Lft1/2 translation. In this way, temporal information is converted into spatial information in the developing embryo.

Results {#sec2}
=======

Regulation of Presumed Long-Range Nodal Target Gene Expression by Fgf Signaling {#sec2.1}
-------------------------------------------------------------------------------

The range of activity of the Nodal signaling pathway in the blastula margin has mainly been inferred from the expression of endogenous target genes, such as *fscn1a* and in particular *ta* (*ntla*) ([@bib5], [@bib23]). However, in addition to Nodal, Fgf signaling is also known to regulate *ta* expression ([@bib22], [@bib40], [@bib43]). Genes encoding Fgf ligands, such as *fgf3* and *fgf8a*, are expressed in the margin ([Figure S1](#mmc1){ref-type="supplementary-material"}A) and are known Nodal targets ([@bib33]), suggesting that Fgf signaling at the margin of blastula-stage embryos is downstream of Nodal signaling ([@bib40]). This is clearly demonstrated by treating embryos with the Nodal inhibitor SB-505124 ([@bib24]), which results in a near complete loss of phosphorylated Erk (P-Erk), a readout for Fgf pathway activity ([@bib12]) ([Figures 1](#fig1){ref-type="fig"}A and 1B).

Given that both Nodal and Fgf signaling are active at the margin, we examined to what extent Fgf signaling regulates endogenous Nodal target genes, focusing on the expression of *ta* and *fscn1a* as examples of long-range genes and *lft1* and *lft2* as examples of short-range target genes ([@bib5], [@bib14], [@bib25]). To inhibit Fgf signaling, wild-type (WT) embryos were treated with the Fgf receptor (FgfR) inhibitor SU-5402 ([@bib35]) or were injected with mRNA encoding a dominant-negative FgfR (dnFgfR) ([@bib2]) ([Figure 1](#fig1){ref-type="fig"}C). Both treatments resulted in a reduction in the size of the expression domains of *ta* and *fscn1a* in the margin of 40%--50% epiboly embryos, but not of *lft1* or *lft2* ([Figure 1](#fig1){ref-type="fig"}D). In fact, *lft2* expression was increased. Similarly, morpholinos (MOs) against *fgf3* and *fgf8*a resulted in a reduction of *ta* expression, but not of *lft1* ([Figure S1](#mmc1){ref-type="supplementary-material"}B). qPCR on SU-5402-treated 50% epiboly embryos confirmed the whole-mount in situ hybridization (WISH) results ([Figure 1](#fig1){ref-type="fig"}E), and as expected, inhibition of Nodal signaling by SB-505124 led to reduction in expression of all four genes ([Figure 1](#fig1){ref-type="fig"}E). Importantly, FgfR inhibition had no effect on C-terminal phosphorylation of Smad2 (P-Smad2) or overall Smad2 levels, demonstrating that Nodal signaling is not affected by Fgf signaling inhibition ([Figure 1](#fig1){ref-type="fig"}F).

To quantitate the effect of inhibiting Fgf signaling on the *ta* expression domain, we performed serial sectioning on *ta*-stained embryos at 40% epiboly. In control embryos, *ta* is expressed in an average of about 10 cell tiers from the margin, whereas expression was reduced to six cell tiers in SU-5402-treated embryos ([Figures 1](#fig1){ref-type="fig"}G and 1H). This indicated that *ta* expression beyond six cell tiers was due to Fgf signaling and not directly dependent on Nodal. In support of this idea, injection of increasing doses of *fgf8a* mRNA into a maternal zygotic (MZ) *tdgf1*^−/−^ background confirmed that Nodal signaling is not required for induction of *ta* by Fgf, excluding a requirement for synergism between Nodal and Fgf signaling for *ta* expression beyond six cell tiers ([Figure S1](#mmc1){ref-type="supplementary-material"}C). This was further confirmed by the observation that inhibition of Nodal signaling from the 16-cell stage resulted in the loss of both *ta* and *lft1* expression, but when Nodal signaling was inhibited from dome stage, only *lft1* expression was severely reduced, whereas the expression of *ta* was unaffected ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Thus *ta* expression is not dependent on Nodal activity after Fgf signaling has been initiated.

Together these data demonstrate that Fgf signaling regulates presumed long-range endogenous Nodal target genes beyond six cell tiers.

Direct In Vivo Visualization of Nodal Signaling {#sec2.2}
-----------------------------------------------

To exclusively monitor Nodal signaling without inputs from other pathways, we generated a transgenic zebrafish Nodal reporter line, specific for Smad2-Smad4-Foxh1-mediated signaling. An *eGFP* reporter gene under the control of three Foxh1 and Smad binding sites, termed activin response elements (AREs) ([@bib19]), was inserted into the zebrafish genome using Tol2-mediated transgenesis (*Tg\[ARE:eGFP\]*) ([Figure 2](#fig2){ref-type="fig"}A). We chose this reporter, which we have extensively characterized in a number of cell culture and developmental contexts ([@bib19], [@bib28], [@bib39]), because Foxh1 is the primary transcription factor required for immediate early Nodal target gene expression ([@bib38], [@bib46]). In addition, Smad2 is the predominant receptor-regulated Smad during blastula stages ([Figure S2](#mmc1){ref-type="supplementary-material"}A), and indeed MZ deletion of Smad2 results in a phenotype identical to MZ*tdgf1*^−/−^ embryos ([@bib14]).

In four independent *Tg(ARE:eGFP)* lines, WISH for *eGFP* mRNA revealed that the reporter was activated in identical domains, excluding any effects caused by different integration sites of the transgene ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B). The *eGFP* expression domains correspond to the expression domains of Nodal ligands ([@bib42]) and include the embryonic margin at blastula stages, axial mesoderm during gastrulation, and the left lateral plate mesoderm during somitogenesis ([Figures 2](#fig2){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}). Incubation of developing *Tg(ARE:eGFP)* embryos with SB-505124 resulted in a strong reduction of *eGFP* staining ([Figure 2](#fig2){ref-type="fig"}B). This was also the case when *foxh1* MOs were injected or when the *Tg(ARE:eGFP)* embryos were bred into a *tdgf1*^−/−^ background ([Figure 2](#fig2){ref-type="fig"}B). The *Tg(ARE:eGFP)* reporter is therefore specific for Smad2-Smad4-Foxh1-mediated Nodal signaling during blastula stages.

To confirm the inducibility of the reporter gene, we exposed dissociated cells from *Tg(ARE:eGFP)* blastula-stage embryos to increasing concentrations of recombinant NODAL and measured gene expression by qPCR. *eGFP* expression was induced at identical NODAL concentrations compared with *ta*, suggesting equal sensitivity of the reporter compared with this target gene ([Figure 2](#fig2){ref-type="fig"}C). Historically the sensitivity of Nodal target genes, such as *ta* and *noto* (*flh*), has been assessed by ectopically expressing Nodal ligands in the animal pole of blastula-stage embryos and using WISH to assay gene expression ([@bib6]). Using NODAL-coated beads in such an assay, we found that the reporter was induced in a domain of similar size to that of *ta* and *noto* ([Figure 2](#fig2){ref-type="fig"}D). Finally, we found no differences in the expression of downstream Nodal genes in 40%--50% epiboly embryos by qPCR and WISH when we compared WT and *Tg(ARE:eGFP)* embryos, demonstrating that the introduction of the transgene had no impact on Nodal signaling ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2E). In conclusion, the *Tg(ARE:eGFP)* zebrafish line is a specific and sensitive biosensor for early Nodal signaling.

Nodal Signaling Is Initiated by Both Maternal and Yolk Syncytial Layer-Derived Ligands {#sec2.3}
--------------------------------------------------------------------------------------

We next used the *Tg(ARE:eGFP)* reporter line to determine how Nodal signaling is initiated in the embryo. At the 8-cell and 1,000-cell stages, no *eGFP* mRNA could be detected ([Figure 2](#fig2){ref-type="fig"}E), indicating that *eGFP* mRNA is not maternally contributed. At sphere stage, however, signaling cells are detected as a localized cluster of *eGFP*-positive cells ([Figure 2](#fig2){ref-type="fig"}F). From 30% epiboly until the onset of gastrulation, Nodal signaling is detected in the entire margin, with a shallow staining gradient running from dorsal to ventral ([Figure 2](#fig2){ref-type="fig"}F). As expected, the overall expression of *eGFP* correlated well with increasing levels of P-Smad2 ([Figure 2](#fig2){ref-type="fig"}G).

We compared the spatial and temporal activation of Nodal signaling in *Tg(ARE:eGFP)* embryos with the expression of core components of the pathway ([Figure S3](#mmc1){ref-type="supplementary-material"}). The genes encoding the receptor Acvr1ba, the co-receptor Tdgf1, and transcription factors Smad2 and Foxh1 are ubiquitously expressed during blastula stages. The activation of signaling therefore depends exclusively on ligand expression ([Figure S3](#mmc1){ref-type="supplementary-material"}).

The discrete signaling domain at sphere stage likely corresponds to the future dorsal side of the embryo, given the known dorsal localization of maternal *ndr1* mRNA ([Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}A) ([@bib21]). We could show that *ndr1* transcripts are polyadenylated before the maternal-to-zygotic transition ([Figure S4](#mmc1){ref-type="supplementary-material"}B), suggesting that maternal *ndr1* is translated and may signal during blastula stages. This was demonstrated by knocking down the Mix-like transcription factor Mxtx2, which is required for zygotic *ndr1* and *ndr2* expression in the yolk syncytial layer (YSL) ([@bib16], [@bib27], [@bib50]). *Tg(ARE:eGFP) mxtx2* morphants retained only a small, dorsal domain that expressed *ndr1*, *ndr2*, and *eGFP* ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Loss of the ventrolateral expression of *ndr1/2* in the blastoderm in *mxtx2* morphants suggested that this *ndr1/2* expression was initiated by Nodal ligands secreted by the YSL and resulted from the ability of Ndr1/2 to induce their own expression. Indeed, embryos incubated with the Nodal inhibitor SB-505124 from the 32-cell stage exhibited complete loss of expression of *ndr1*/*2* in the blastoderm of 40% epiboly embryos, whereas expression of *ndr1/2* in the YSL was not affected ([Figure S4](#mmc1){ref-type="supplementary-material"}D) ([@bib16]).

Thus, maternally provided Ndr1 activates Nodal signaling in dorsal-most embryonic cells before the initiation of signaling in the entire margin by Ndr1/2 synthesized in the YSL ([Figure S4](#mmc1){ref-type="supplementary-material"}E).

Endogenous Nodal Signaling Extends up to Five or Six Cell Tiers from the Margin {#sec2.4}
-------------------------------------------------------------------------------

The *Tg(ARE:eGFP)* zebrafish line provides an ideal tool to investigate the dimensions of the Nodal signaling domain at the margin. To initially investigate whether there was any Nodal signaling beyond the ligand-expressing domain, we performed double fluorescent WISH for *ndr2* and *eGFP* in 30% epiboly embryos, when the Nodal signaling domain is expanding ([@bib14], [@bib25]). Although individual signaling cells were occasionally observed directly adjacent to *ndr2*-expressing cells, no *eGFP*-positive cells were detected further beyond the ligand expression domain ([Figure S5](#mmc1){ref-type="supplementary-material"}A). To determine the extent of Nodal signaling more rigorously, 40%--50% epiboly *Tg(ARE:eGFP)* embryos were stained for *eGFP*, *ndr1*, *ndr2*, *lft1*, and *lft2* expression, sectioned, and quantitated ([Figures 3](#fig3){ref-type="fig"}A and 3B). The expression of *eGFP*, *ndr1*, *ndr2*, and *lft1* was limited to an average of about five cell tiers, whereas *lft2* expression was detected in only two to three cell tiers from the margin. To confirm that these findings were not due to a lack of sensitivity of the WISH, we analyzed the expression of *sox3*, which is repressed by Nodal signaling in the margin ([@bib5]). Significant repression was seen in up to six cell tiers from the margin ([Figure 3](#fig3){ref-type="fig"}A). Importantly, staining for all induced Nodal target genes, including *eGFP*, was consistently stronger in a cluster of cells directly proximal to the YSL, where signaling originates ([Figure 3](#fig3){ref-type="fig"}A).

To corroborate the data obtained from the sections, we used a direct readout of the Nodal pathway, fluorescent immunostaining of whole-mount 50% epiboly embryos with an antibody against P-Smad2. For comparison, we also stained for P-Erk. Nuclear P-Smad2 staining was observed exclusively in the margin and, as expected, in a smaller domain than the P-Erk staining ([Figure 3](#fig3){ref-type="fig"}C). To quantitate the size of the P-Smad2-positive domain, we imaged the embryos at the margin, used MetaMorph software to generate normalized nuclear staining intensities, and measured the distance of each nucleus from the margin in control- and SB-505124-treated embryos. P-Smad2 staining above background was found up to five to six cell tiers (80--90 μm) from the margin in a steep gradient, which was abolished in SB-505124-treated embryos ([Figures 3](#fig3){ref-type="fig"}D, 3E, and [S5](#mmc1){ref-type="supplementary-material"}B--S5D). The staining was strongest in the nuclei of cells nearest the YSL. Taken together with our observations from the *Tg(ARE:eGFP)* reporter line, these data demonstrate that Nodal signaling occurs in five to six cell tiers from the margin, closely mirroring the expression of the ligands.

Temporal Regulation of Lft1 Protein Translation during Early Blastula Stages {#sec2.5}
----------------------------------------------------------------------------

Our data demonstrate that the Nodal ligands and antagonists are co-expressed at the margin of late blastula-stage embryos, and moreover, Nodal activity is restricted to these cells. This raised two important questions. First, if the ligands and antagonists are co-expressed, how does signaling occur at all? Second, given that all cells are competent to signal at blastula stages and Nodal signaling induces the expression of the ligands, why does signaling not spread throughout the embryo?

To address these questions, we first determined to what extent Lft1/2 regulate Nodal signaling in early and late blastula-stage embryos. The Lft1/2 proteins are known to inhibit signaling by sequestering Tdgf1 and possibly also Nodal itself ([@bib8], [@bib9]). As expected, injection of *lft1/2* MOs led to an expansion of the Nodal signaling domain at 50% epiboly, which was confirmed by qPCR ([Figures 4](#fig4){ref-type="fig"}A and 4B). At dome stage, however, there was no increase in the size of the Nodal signaling domain, suggesting that Lft1/2 do not regulate Nodal signaling at early stages. Although there is an offset in the appearance of *ndr1/2* and *lft1/2* mRNA due to the presence of maternal *ndr1* transcripts, the lack of an early role for Lft1/2 is not explained by an absence of *lft1/2* mRNA at sphere and dome stages ([Figures 4](#fig4){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}). We hypothesized therefore that a delay in translation of the Lft1/2 proteins could account for the inability of Lft1/2 to regulate Nodal signaling at dome stage. Both *lft1* and *lft2* transcripts were readily polyadenylated by sphere stage ([Figure 4](#fig4){ref-type="fig"}D), suggesting that lack of polyadenylation could not account for any delay in Lft1/2 translation.

To measure endogenous protein levels directly, we raised polyclonal antibodies for Lft1 and Lft2 and thoroughly characterized them ([Figure S6](#mmc1){ref-type="supplementary-material"}). Although both antibodies recognized their corresponding target protein when overexpressed ([Figure S6](#mmc1){ref-type="supplementary-material"}B), only the Lft1 antibody was able to detect endogenous protein, so we focused on this family member. The major band detected by western blot corresponding to endogenous Lft1 migrated by SDS-PAGE with a molecular weight of ∼40 kD ([Figure S6](#mmc1){ref-type="supplementary-material"}C). Mutation analysis indicated that this product arose from cleavage at the first Furin cleavage site (marked as C1 in [Figure S6](#mmc1){ref-type="supplementary-material"}A), and we could demonstrate that this product was active ([Figures S6](#mmc1){ref-type="supplementary-material"}D--S6F). The same 40 kD band was also detected in embryos injected with *ndr1* mRNA ([Figure S6](#mmc1){ref-type="supplementary-material"}G). Levels of endogenous Lft1 were barely detectable by western blotting at dome stage and 30% epiboly but increased at 50% epiboly ([Figures 4](#fig4){ref-type="fig"}E and 4F). Thus, endogenous Lft1 protein levels remain low until 50% epiboly, despite readily detectable mRNA levels at all these time points. This suggested that the lack of an early role for Lft1/2 could be due to low protein abundance and led us to hypothesize that repressed Lft1/2 translation creates a window of opportunity for Nodal signaling to become established.

*miR-430* Creates a Temporal Window for Nodal Signaling by Regulating Lft1/2 Levels {#sec2.6}
-----------------------------------------------------------------------------------

During blastula stages, the *miR-430* family of miRNAs have been reported to block translation, without affecting polyadenylation ([@bib4], [@bib10]). We reasoned therefore that the activity of *miR-430* could be responsible for the repressed translation of Lft1/2 proteins to create a temporal window for Nodal to activate signaling. *miR-430* pri-miRNA is expressed in the nuclei of all cells in the blastoderm, immediately after activation of zygotic transcription ([Figure 5](#fig5){ref-type="fig"}A). We also confirmed a ubiquitous expression pattern for mature *miR-430a* and *miR-430b* at 50% epiboly ([Figure 5](#fig5){ref-type="fig"}B) and demonstrated that mature *miR-430a* and *miR-430b* are directly processed upon expression ([Figure 5](#fig5){ref-type="fig"}C). *miR-430c* was not detected by either WISH or northern blotting, but RNA sequencing data demonstrated that *miR-430c* is much less abundant than *miR-430a* and *miR-430b* (unpublished data). Thus, the *miR-430* family is abundant, ubiquitously expressed, and readily processed during mid to late blastula stages.

To determine the role of *miR-430* in the regulation of Lft1/2 protein translation, we designed three MOs that prevented processing of mature *miR-430a*, *miR-430b*, and *miR-430c*. Injection of these MOs into one-cell-stage embryos resulted in a phenotype resembling MZ *dicer* mutants at 22 hpf ([Figure S7](#mmc1){ref-type="supplementary-material"}A) ([@bib20]). Furthermore, they abolished *miR-430a* staining at 50% epiboly and reduced *miR-430a*, *miR-430b*, and *miR-430c* expression, as determined by qPCR, by 89% ([Figures S7](#mmc1){ref-type="supplementary-material"}B and S7C). Co-injection of *miR-430* MOs with a *GFP* reporter containing either three *miR-430* binding sites or a *GFP* reporter with the *lft2* 3′UTR, which contains a single *miR-430* binding site, resulted in increased translation compared to control MOs ([Figure S7](#mmc1){ref-type="supplementary-material"}D). Together, these experiments demonstrate the efficacy of the *miR-430* MOs.

We next injected equal amounts of control or *miR-430* MOs and performed western blotting for P-Smad2 and Lft1 at several blastula stages. In control MO-injected embryos, Lft1 protein was not detectable until 30% epiboly and increased at 50% epiboly, as observed for Lft1 protein expression in WT embryos (compare [Figure 4](#fig4){ref-type="fig"}E with [Figure 5](#fig5){ref-type="fig"}D). Importantly, this was accompanied by a gradual increase of P-Smad2 over time. In contrast, injection of *miR-430* MOs led to premature translation of Lft1 from dome stage, and this coincided with lower overall accumulation of P-Smad2 ([Figure 5](#fig5){ref-type="fig"}D). Interestingly, the level of Lft1 protein in dome-stage *miR-430* morphants was similar to the maximal level of Lft1 protein measured at 50% epiboly in control MO-injected embryos, suggesting that there may be a threshold level of Lft1 that is inhibitory.

To determine whether reduced signaling in the *miR-430* morphants was due to premature translation of Lft1/2 and to investigate the spatial consequences for Nodal signaling of the loss of *miR-430*, we injected *miR-430* MOs and/or *lft1/2* MOs into *Tg(ARE:eGFP)* embryos and assayed Nodal activity (*eGFP*) and *ndr1* levels at 30% epiboly. Injection of *lft1/2* MOs alone resulted in a modest increase in *eGFP* and *ndr1* staining ([Figure 5](#fig5){ref-type="fig"}E), whereas injection of *miR-430* MOs led to a reduction in *eGFP* staining in the blastoderm, consistent with the inhibition of the Nodal signaling pathway we observed using P-Smad2 levels as a readout ([Figure 5](#fig5){ref-type="fig"}D). When *lft1/2* MOs and *miR-430* MOs were co-injected, signaling was activated in the entire blastoderm, and this was accompanied by a similar expansion of *ndr1* expression ([Figure 5](#fig5){ref-type="fig"}E). Importantly, this spreading of *eGFP* staining in *lft1/2* and *miR-430* MO-co-injected embryos was due to Nodal signaling, because it was completely blocked by incubating double morphants with SB-505124 ([Figure 5](#fig5){ref-type="fig"}F). The further spreading of signaling following combined knockdown of *lft1/2* and *miR-430* is readily explained by the regulation of Ndr1 translation by *miR-430* in the absence of Lft1/2 (see [Figure 7](#fig7){ref-type="fig"}A) ([@bib10]). Together, these experiments demonstrate that *miR-430* delays Lft1/2 translation to create a temporal window for Nodal to activate signaling.

Duration of Ligand Exposure Translates Directly into Increasing Signaling Levels {#sec2.7}
--------------------------------------------------------------------------------

Our data demonstrate that a temporal window for Nodal signaling activation determines the size of the Nodal signaling domain and predict that once Lft1/2 levels reach a certain threshold, Nodal signaling is unable to spread to adjacent cells. We therefore tested if blocking signaling activation by recombinant mouse LEFTY1 (mLEFTY1) is dose dependent in dissociated embryonic cells. A 5-fold excess (calculated by mass) of mLEFTY1 over human recombinant NODAL led to a near complete inhibition of signaling activation as read out by western blotting for P-Smad2 and endogenous zebrafish Lft1, which monitors the transcriptional output of the pathway ([Figure 6](#fig6){ref-type="fig"}A). Thus, Lft1/2 proteins can reach an inhibitory concentration at which signaling can no longer be activated.

Next we determined if duration of exposure to NODAL directly corresponds to increasing levels of signaling. When blastula-stage cells were exposed to 50 ng/ml NODAL and then inhibited with a blocking concentration of 500 ng/ml mLEFTY1 at different time points, P-Smad2 and endogenous Lft1 levels were indeed proportional to the duration of ligand exposure ([Figure 6](#fig6){ref-type="fig"}B).

Finally, we investigated how rapidly signaling is blocked when Lft1/2 levels reach inhibitory concentrations. This is a crucial issue, as we observe that Nodal signaling in vivo (as read out by *eGFP*, *ndr1*, *ndr2*, *lft1*, and *lft2*) is sustained in the margin for several hours after Lft1 levels reach an inhibitory concentration at around 50% epiboly ([Figure S3](#mmc1){ref-type="supplementary-material"}). Dissociated embryonic cells were therefore exposed to NODAL for 1 hr, and then signaling was inhibited by addition of mLEFTY1 for 2 hr. We observed that P-Smad2 levels decreased slowly, compared with the rapid termination of signaling with SB-505124 ([Figure 6](#fig6){ref-type="fig"}C). This demonstrated that although signal activation is blocked by Lefty, Nodal signaling is sustained for some time, presumably because of continued signaling from internalized receptor complexes in early endosomes ([@bib29], [@bib47]).

In conclusion, our data show that activation of Nodal signaling in blastula-stage cells can occur until Lft1/2 levels reach inhibitory concentrations. Moreover, the levels of P-Smad2, and as a result transcription, are proportional to the duration of signal activation. This can be maintained for some time after inhibitory Lft1/2 concentrations are reached, while no new signaling is activated.

Discussion {#sec3}
==========

A Temporal Window of Signaling Activation Determines the Size and Shape of the Nodal Signaling Domain {#sec3.1}
-----------------------------------------------------------------------------------------------------

Here we describe a specific and sensitive Nodal reporter line that has enabled us to visualize endogenous Nodal signaling in developing zebrafish embryos, without overexpression of any pathway components. We show that signaling is initiated on the dorsal side because of maternally provided Ndr1. Ventral and lateral signaling arises as a result of Ndr1/2 expression in the YSL, which then spreads toward the animal pole as a result of autoregulation. Nodal signaling in the margin reaches a maximum of six cell tiers, which we demonstrate by P-Smad2 immunostaining and reporter activity. We find no evidence of signaling beyond the cells that express the ligand, and moreover, these same cells additionally express the Nodal antagonists Lft1/2. Spreading of presumed long-range Nodal target genes, such as *ta*, that are activated beyond the ligand expression domain, is actually due to Fgf signaling, activated downstream of Nodal. Our data support a model whereby a temporal window for Nodal signaling activation dictates the dimensions of the Nodal signaling domain ([Figure 7](#fig7){ref-type="fig"}). Thus, temporal information is translated into spatial information in the developing embryo.

The crucial determinant of the temporal window is the delayed translation of the Lft1/2 proteins, which is mediated by *miR-430*. In addition, maternally provided *ndr1* transcripts and the production of Ndr1/2 by the YSL allow Nodal signaling to be initiated in the blastoderm, before transcription of *lft1/2* ([Figure 7](#fig7){ref-type="fig"}C). *ndr1/2* expression in the YSL activates signaling in adjacent cells in the blastoderm. Because of positive feedback, the blastoderm cells produce more Ndr1/2, while Lft1/2 levels remain relatively low because of the ubiquitous synthesis of *miR-430*. In these conditions, Nodal signaling can be activated in neighboring cells until extracellular Lft1/2 levels reach inhibitory concentrations. Therefore, the duration for which Lft1/2 levels are repressed dictates the size of the Nodal signaling domain. How the repressive action of *miR-430* is lifted at 50% epiboly to allow Lft1/2 translation is not yet known and requires further investigation. Although inhibitory Lft1/2 levels prevent further activation of signaling, and hence additional spreading of Nodal signaling, cells already responding to Nodal will continue to signal for several hours, because this occurs from internalized receptors that are refractory to Lft1/2 inhibition. A consequence of our proposed mechanism is that cells directly adjacent to the YSL activate Nodal signaling for the longest duration. This likely explains the more intense P-Smad2 staining in these cells relative to those further from the margin. We therefore propose that Nodal signaling at the margin at blastula stages is dictated by an interplay among ligand, ligand antagonist, and a miRNA, with a differential in timing between ligand and antagonist production being the key determining factor.

The size and shape of the Nodal signaling gradient had previously been thought to be regulated by a reaction-diffusion system ([@bib34], [@bib36], [@bib42]). Here we propose an alternative mechanism whereby the size of the domain is dictated by the delay in Lefty translation. Although the Nodal/Lefty ligand/antagonist pair has many features of a reaction-diffusion system, we have uncovered one aspect that is incompatible. In reaction-diffusion models, which were originally conceived as pattern-forming chemical reactions, a homogeneous distribution of activator and inhibitor are unstable, and a local elevation of activator initiates formation of a gradient ([@bib34]). Integral to this model is the ability of the diffusing antagonist to immediately inhibit activator function at a distance. For Nodal and Lefty, this cannot happen, because once Nodal signaling is activated it occurs from internalized receptors and is therefore insensitive to Lefty inhibition, except over prolonged time frames.

A Temporal Gradient of Nodal Signaling and Cell Fate Decisions {#sec3.2}
--------------------------------------------------------------

Our data suggest that spatially graded activity of the Nodal signaling pathway is mainly the result of different durations of exposure to Ndr1/2 over time, as opposed to exposure to different concentrations. We observe two graded signaling domains in *Tg(ARE:eGFP)* embryos that are both explained by timing of ligand exposure. During blastula stages, a shallow signaling gradient runs from dorsal to ventral. This is readily explained by the fact that dorsal cells are exposed to Nodal for a longer period than ventrolateral cells, because maternally provided Ndr1 signals dorsally before Ndr1/2 produced in the YSL induces signaling in the blastoderm margin. In addition, we found a clear vegetal-to-animal gradient within the ligand-expression domain using P-Smad2 immunostaining in late blastula-stage embryos, and we also observed that cells directly adjacent to the YSL expressed higher levels of all Nodal target genes, including the *eGFP* reporter gene, reflecting higher levels of signaling. Again, cells directly adjacent to the YSL are exposed to Ndr1/2 for the longest period of time. The importance of duration of exposure is further supported by our ex vivo experiments with dissociated embryonic cells. The long-term functional consequences of this were demonstrated in previously published work, which linked cell fates to the duration of exposure to Nodal signals ([@bib24]). Thus, our model explains how concentration and duration of signaling can be translated into positional information. Finally, the importance of timing of signaling activation also rationalizes the normal development of *ndr1* mutants ([@bib17], [@bib26], [@bib30]). Mesendoderm development in these mutants is largely normal, although delayed. This is explained by the fact that Ndr2 compensates for the lack of Ndr1, but its expression is delayed, because there is no maternal Ndr2.

From the sectioning of *Tg(ARE:eGFP)* embryos and immunostaining for P-Smad2, it is clear that Smad2-Smad4-Foxh1-dependent Nodal signaling is confined to 5--6 cell tiers from the margin, which could imply that all mesendodermal cells arise from this domain. This finding seems to contradict lineage-tracing studies that show that some mesodermal precursors are located up to 12 cell tiers away from the margin (e.g., see [@bib13], [@bib49]). Although these lineage-tracing studies have provided valuable insight into the overall spatial distribution of mesendoderm precursors, they cannot themselves determine the extent of Nodal signaling. This is because although Nodal signaling is required for mesendoderm formation, not all cells that become mesendoderm have necessarily experienced Nodal signaling directly.

Our understanding of how morphogens activate graded signaling in tissues has been dominated by the pre-molecular era assumption that secreted ligands diffuse from a source to form concentration gradients, and this assumption has naturally progressed into the formulation of models that include diffusion as a major determinant in patterning by morphogens. Although in some contexts, such as the establishment of left-right asymmetry, Nodal can act at long range ([@bib45]), the work presented here shows that the formation of the Nodal signaling domain at the blastula margin is explained by short-range signaling activation, signaling dynamics, and transcriptional/translational regulation.

Experimental Procedures {#sec4}
=======================

For detailed experimental procedures, see the [Supplemental Information](#app2){ref-type="sec"}.

Recombinant Proteins and Inhibitors {#sec4.1}
-----------------------------------

Human NODAL (3218-ND/CF; R&D) was dissolved in 4 mM HCl at 100 μg/ml, aliquoted in non-stick tubes, and used at 40 ng/ml (unless stated otherwise) without freeze-thawing. Recombinant mLEFTY1 was dissolved according to the manufacturer's instructions (994-LF/CF; R&D). The inhibitors SB-505124 (3263; Tocris Bioscience) and SU-5402 (572631; Calbiochem) were dissolved in DMSO and used in embryos at 50 and 10 μM respectively. In dissociated embryonic cells, SB-505124 was used at 10 μM.

Dissociated Embryonic Cell Culture {#sec4.2}
----------------------------------

For blastula-stage cell cultures, up to 1,000 embryos were dechorionated using 2 mg/ml Pronase (11459643001; Roche) in 10 ml E3 medium. The dechorionated embryos were washed extensively in E3 medium and once with calcium-free Ringers buffer to remove the Pronase ([@bib31]). The embryos were manually disrupted in calcium-free Ringers buffer using a P200 pipette in 6 cm bacterial dishes, collected by centrifugation at 1,000 × *g* for 5 min, and then resuspended at ∼50 embryos/ml in Leibovitz's L15 Medium (11415-064; GIBCO) supplemented with 3% fetal bovine serum (FBS). Cells were plated in 24-well tissue culture plates coated with poly-L lysine (P4707; Sigma) and allowed to attach for 30 min. These experiments were performed at 28°C using pre-warmed buffers in triplicate. The experiments were terminated by aspirating the medium and freezing the plates at −80°C.

Whole-Mount Immunofluorescence and Quantification of P-Smad2 Staining {#sec4.3}
---------------------------------------------------------------------

Embryos were fixed in 4% paraformaldehyde in PBS overnight, dehydrated to 100% methanol, and stored at −20°C until processing. For whole-mount immunofluorescence, embryos were rehydrated to PBS and incubated in cold acetone at −20°C for 20 min. Blocking and antibody incubations were performed in 10% FBS and 1% Triton X-100 in PBS, and washes were performed in PBS/1% Triton. The following primary antibodies were used: α-P-Smad2/3 (8828; Cell Signaling Technology) and α-P-Erk (M8159; Sigma). Note that because of the lack of Smad3 at blastula stages, we solely detect P-Smad2 with the α-P-Smad2/3 antibody. DAPI was used to stain nuclei, and images were acquired on a Zeiss LSM 780 confocal microscope. For quantification of P-Smad2 intensity in deep cells, MetaMorph Software (Molecular Devices) was used to generate P-Smad2 to DAPI ratios from at least three single optical slices per embryo, in three individual DMSO or SB-505124 treated, 50% epiboly embryos. Care was taken not to select mitotic or overlapping nuclei or nuclei from the enveloping layer. To measure the distance of a nucleus to the margin, a line was drawn laterally at the vegetal edge of the margin, and the distance to the nucleus perpendicular to the margin was measured using the MetaMorph Software. To normalize the staining intensity for each embryo, the average ratio of an area further than 11 cell tiers from the margin (\>165 μm) was subtracted from each measurement. The data were divided in 15 μm bins, representing the average size of a deep cell at 50% epiboly (unpublished data; [@bib14]). The averages of the binned data for each cell tier, comparing DMSO and SB-505124 treatment, were used for testing for statistical significant differences using paired t tests with a 95% confidence interval.

Animal Experimentation {#sec4.4}
----------------------

All the zebrafish work was carried out under a UK Home Office License under the Animals (Scientific Procedures) Act 1986. The license underwent full ethical review and approval by the Cancer Research UK London Research Institute Animal Ethics Committee.
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![Expression of *ta* and *fscn1a* in the Margin Is Regulated by Fgf Signaling\
(A) Whole-mount immunofluorescence for phosphorylated Erk (P-Erk) in DMSO- and SB-505124-treated 50% epiboly embryos. DAPI labels the nuclei.\
(B) Western blot for P-Erk in pooled 50% epiboly embryos treated with indicated compounds. Actin is a loading control.\
(C) Western blot for P-Erk and total Erk in pooled 40%--50% embryos after control treatment or FgfR inhibition. Actin is a loading control.\
(D) WISH for *ta*, *fscn1a*, *lft1*, and *lft2* in control embryos, embryos incubated with SU-5402, or embryos injected with mRNA encoding dnFgfR, at 40%--50% epiboly. For *fscn1a*, animal views are shown. Red brackets outline the width of the WT *ta* expression domain.\
(E) qPCR for indicated Nodal target genes on pooled 50% epiboly embryos treated with DMSO (D), SB-505124 (SB), or SU-5402 (SU). Depicted is the mean expression ± SD normalized to *eef1a1l1* levels and compared with levels in DMSO-treated cells (^∗^p \< 0.01, t test; n = 3). ns, not significant.\
(F) Western blot for P-Smad2 and Smad2 in pooled 40%--50% embryos treated with the indicated compounds. Mcm6 is a loading control.\
(G) Sections of DMSO- and SU-5402-treated 40%--50% epiboly embryos stained for *ta*.\
(H) Quantification of the number of cell tiers from the margin that express *ta*. Depicted is the mean ± SD (^∗^p \< 0.01, Mann-Whitney U test; n \> 50).\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![The *Tg(ARE:eGFP)* Zebrafish Line Is a Sensitive and Specific In Vivo Nodal Reporter\
(A) Top: schematic representation of the Nodal reporter gene construct. Bottom: WISH for *eGFP* in *Tg(ARE:eGFP)* embryos at 50% epiboly (above, lateral view; below, animal view) and 22 somite stages. Dashed line indicates the midline. A, anterior; D, dorsal; lpm, lateral plate mesoderm; P, posterior; V, ventral.\
(B) WISH for *eGFP* in control-treated *Tg(ARE:eGFP)* embryos or after inhibition of Nodal signaling by SB-505124 from the 32-cell stage (left), injection of *foxh1* MO (middle), or in a *tdgf1*^−/−^ background (right) at 50% or 30% epiboly. For the *tdgf1*^−/−^ experiment, a clutch of 16 embryos from a heterozygous incross was analyzed. Note that 25% of embryos lack *eGFP* staining.\
(C) qPCR for *eGFP*, *ta*, and *odc1* on dissociated blastula-stage *Tg(ARE:eGFP)* embryonic cells. Depicted is the mean relative expression compared with untreated cells, normalized to *eef1a1l1* levels from one representative experiment ± SD.\
(D) Polystyrene beads soaked in recombinant human NODAL were implanted into the animal pole of 1000-cell *Tg(ARE:eGFP)* embryos. Once the embryos had reached ring stage, they were stained for the indicated genes. Animal views are shown. A red spot indicates the position of the bead.\
(E) *eGFP* expression at 8-cell and 1,000-cell stages.\
(F) *eGFP* expression in sphere, 30% and 50% epiboly *Tg(ARE:eGFP)* embryos. Arrow indicates expression in dorsal cells.\
(G) Western blot for phosphorylated Smad2 (P-Smad2) in blastula stage embryos treated with or without SB-505124. Mcm6 is a loading control.\
See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Extent of Nodal Signaling and Target Gene Expression in *Tg(ARE:eGFP)* Embryos\
(A) Sections of 40%--50% epiboly embryos, stained for *eGFP*, *ndr1*, *ndr2*, *lft1*, *lft2*, and *sox3*. Sections were counterstained with Nuclear Fast Red. The black line indicates the border of the YSL and blastoderm; arrowheads indicate five cell tiers.\
(B) Quantification of the number of cell tiers that express indicated Nodal target genes, calculated from the margin. Depicted is the mean number of cell tiers ± SD (n = 18).\
(C) Whole-mount immunofluorescence of 50% epiboly embryos for P-Smad2 and P-Erk. DAPI labels nuclei. Depicted is a single optical slice of a lateral view.\
(D) Immunofluorescence for P-Smad2 in DMSO- and SB-505124-treated 50% embryos. Depicted is a Z-projection of a lateral view. The white dashed line indicates the border of the margin.\
(E) Quantification of P-Smad2 immunofluorescence normalized to background signal as a function of the number of cell tiers from the margin in DMSO- and SB-505124-treated embryos. Data were binned in 15 μm intervals to represent the average size of a cell in 50% epiboly embryo ([@bib14]). Depicted are means of each bin obtained from multiple optical slices ± SEM (^∗^p \< 0.0, t test, n = 3, comparing DMSO- and SB-505124-treated intensities for each cell tier).\
See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Delayed Translation of Lft1/2 Levels during Early Blastula Stages\
(A) WISH for *eGFP* in dome and 50% epiboly *Tg(ARE:eGFP)* embryos, injected with control or *lft1/2* MOs. Animal views are shown at left, and ventrolateral sections are shown at right.\
(B) qPCR for *eGFP* mRNA on pooled dome and 50% epiboly embryos. Depicted are means ± SEM (^∗^p \< 0.01, t test; n = 6).\
(C) qPCR for *ndr1*, *lft1*, and *lft2* at different stages. The percentage of mean maximal expression ± SD from a representative experiment performed in triplicate is shown.\
(D) Extension poly-A test (ePAT) for *lft1* and *lft2* mRNA. Silver stained non-denaturing polyacrylamide gels are shown indicating total and polyadenylated (poly-A) mRNA.\
(E) Western blot showing protein expression of endogenous Lft1 and phosphorylated Smad2 in pooled, blastula-stage embryos. Treatment with SB-505124 is shown to confirm the Lft1 band. Mcm6 is a loading control.\
(F) Quantification of Lft1 protein expression from sphere to 50% epiboly. Depicted are the average band intensities of three independent blots, normalized to levels at 50% epiboly ± SD (^∗^p \< 0.05, t test).\
See also [Figure S6](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Temporal Regulation of Lft1/2 Translation by *miR-430*s\
(A) WISH for *pri-miR-430* at indicated stages.\
(B) WISH using LNA probes for mature *miR-430a* and *miR-430b* at 50% epiboly.\
(C) Northern blot for *miR-430a* and *miR-430b* at indicated stages using the same probes as in (B). mat, mature miRNA; pre, pre-miRNA.\
(D) Western blot for endogenous Lft1 and P-Smad2 in pooled, blastula-stage embryos injected with control or *miR-430* MOs. Mcm6 is a loading control. epi, epiboly.\
(E) Lateral views of WISH for *eGFP* reporter and *ndr1* in 30% epiboly, *Tg(ARE:eGFP)* embryos injected with MOs against *lft1/2*, *miR-430* or both.\
(F) WISH for eGFP mRNA in 40% epiboly *Tg(ARE:eGFP)* embryos injected with control or combined *lft1/2* and *miR-430* MOs and treated with DMSO or SB-505124. Animal views are shown.\
See also [Figure S7](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![Nodal Signaling Dynamics\
(A) Western blot for P-Smad2 and endogenous Lft1 on dissociated blastula-stage embryonic cells. Cells were exposed to 100 ng/ml NODAL for 2 hr, with or without increasing doses of mLEFTY1. Actin is a loading control. Lft1 runs as two bands: the upper one is unprocessed, and the lower is the 40 kD processed band. SB, SB-505124.\
(B) Cells were treated ± 10 μM SB-505124 or with 50 ng/ml NODAL and then with 500 ng/ml mLEFTY1 at the indicated time points. All cells were collected at the 3 hr time point and western blotted as indicated.\
(C) Top: scheme of the experimental setup. Arrows denote addition of the indicated compound or recombinant protein. All cells were collected at the 3-hr time point. Bottom: western blot using the indicated antibodies. Times (hours) of incubation with 10 μM SB-505124, NODAL, or mLEFTY1 are shown.](gr6){#fig6}

![The Nodal Temporal Window Model\
(A) Schematic showing how *miR-430*, Lft1/2, and *ndr1/2* regulate one another.\
(B) Model of temporal window for Nodal signaling activation, controlled by *miR-430* and Lft1/2. Ndr1/2 protein levels increase (dark blue line) over time because of autoregulation at low Lft1/2 concentrations (red line) until sufficient Lft1/2 is translated to inhibit signaling activation (pink shading) just before the onset of gastrulation. This process is controlled by *miR-430*s (green line, middle), which allows slow accumulation of signaling (light blue line, right). G, gastrulation; 1K, 1,000-cell stage.\
(C) In vivo mesendoderm induction over time according to the Nodal temporal window model. YSL-expressing Ndr1/2 is shown in purple; cells responding to Nodal are in blue, with dark blue denoting those experiencing the longest signaling duration. Cells expressing *miR-430* are denoted with green nuclei, and pink shading depicts cells in which Lft1/2 levels have reached an inhibitory threshold. Note that by 50% epiboly the cells beyond the Nodal signaling domain are responding to Fgf, and this accounts for expression of mesodermal genes such as *ta* and *fscn1a* in these cells. For details, see text. DC, deep cells; EVL, enveloping layer.](gr7){#fig7}
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